Agoracom Blog Home

Posts Tagged ‘Hemp’

North Bud Farms $NBUD.ca Arranges Private Placement Financing and Provides Corporate Update $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:09 AM on Wednesday, May 15th, 2019
  • Announced a non-brokered private placement of up to 13,333,333 units, at a price of $0.30 per unit, for gross proceeds of up to $4 million
  • Company plans to use the net proceeds of the offering to hire additional staff for its Canadian operations, pursue M&A opportunities in the United States, including new state license applications, and for general working capital purposes.

Insiders of NORTHBUD have Committed $1 Million as Lead Order

TORONTO, May 15, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) announces a non-brokered private placement of up to 13,333,333 units, at a price of $0.30 per unit, for gross proceeds of up to $4 million. Each unit will be comprised of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to acquire an additional share at a price of $0.40 for a period of 24 months from the date of closing of the offering. Insiders of the Company have demonstrated their commitment to the continued success of the Company by committing to a lead investment of $1 million in the proposed offering. The Company plans to use the net proceeds of the offering to hire additional staff for its Canadian operations, pursue M&A opportunities in the United States, including new state license applications, and for general working capital purposes.

“These funds will be essential to fund ongoing acquisition efforts in the United States and prepare our Canadian production facility for operations,” said Ryan Brown, CEO of North Bud Farms.

The offering is expected to be completed on or before May 31, 2019, subject to the receipt of all necessary regulatory approvals. All securities issued pursuant to the offering will be subject to a four-month hold period in accordance with applicable Canadian securities laws.

As mentioned, certain directors, officers and other insiders have committed to participate in the offering. Accordingly, any such participation would be considered a “related party transaction” under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on the exemptions from the formal valuation requirements and majority of the minority shareholder approval requirements of MI 61-101 contained in Section 5.5(a) and Section 5.7(1)(a) in respect of any such related party transaction on the basis that the fair market value of the transaction does not exceed more than 25% of the Company’s market capitalization. The Company expects to file a material change report in respect of any related party transaction on SEDAR prior to the closing of the offering, the whole as required by MI 61-101.

Eureka Vapor LLC Update

The Company is pleased to update shareholders on the status of its planned strategic acquisition of multi-state licensed operator, Eureka Vapor (“Eureka”), as the companies continue to work towards completing a definitive agreement. Based on projected timelines for the completion of the audit of Eureka’s financial statements, the companies expect to sign a definitive agreement in the third quarter of the 2019 calendar year.

“We are excited to be joining forces with NORTHBUD to drive strong long-term revenue growth in both Canada and the United States,” said Justin Braune, CEO of Eureka Vapor. “The Eureka team continues to evaluate synergistic acquisitions in multiple U.S. states to expand both the Eureka Vapor and NORTHBUD brands post-closing of our transaction.”

Corporate Update

The Company is in the final stages of preparation for submission of the required evidence package to Health Canada for its cannabis production facility located in Low, Quebec. Consultants have scheduled the evidence package for the end of June and it will be submitted to Health Canada upon its completion.

“We are very excited to be nearing completion of this project,” said Ryan Brown, CEO of North Bud Farms. “We are equally encouraged by recent changes in the application process that will allocate more resources to companies who are operationally ready. The Company will provide an update post submission of the evidence package.”

About North Bud Farms Inc.

North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act. North Bud Farms Inc. is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. Forward-looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Bougainville $BOG.ca Signs a Sponsored Research Agreement for a CBD Energy Drink With Israeli Based R&D Company $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 12:29 PM on Tuesday, May 14th, 2019
  • Signed a Sponsored Research Agreement to develop a one of a kind water soluble cannabis-based (CBD) supplement energy drink to improve workout performance
  • Bougainville agrees to fund certain CBD-based research projects like CBD-Oils, CBD-Creams, and CBD-Supplements.

VANCOUVER, British Columbia, May 14, 2019 — Bougainville Ventures Inc. (CSE:BOG) (Frankfurt:8BV) is pleased to announced it has signed a Sponsored Research Agreement to develop a one of a kind water soluble cannabis-based (CBD) supplement energy drink to improve workout performance.

Pursuant to its agreement with an Israeli based research firm Bougainville agrees to fund certain CBD-based research projects like CBD-Oils, CBD-Creams, and CBD-Supplements. The first project will be to develop a formula, which will be a water soluble cannabis-based (CBD) supplement to boost energy and to improve workout performance.

Terms of the Agreement

Bougainville will pay a 5% Royalty from the sale, transfer or order disposition of the product, for a period of six (6) years from the completion of the product. Bougainville will have exclusive rights to commercialize the product in Canada and first right of refusal to commercialize the product in the US.

Bougainville Shall pay the Israeli based research firm $25,000 USD upon the execution of the Definitive Agreement by non-refundable check dated July 1, 2019. And an additional $50,000 USD shall be paid by Bougainville in favor of the research firm based on milestones.

Israel is at the Forefront of Medical Cannabis Research

Israel is one of the most progressive nations for medical marijuana research comes courtesy of the government’s involvement. Not only do they sponsor the majority of clinical trials, but the Israeli military has endorsed the cannabinoid THC as part of a treatment program for post-traumatic stress disorder (PTSD). In 2017 Israel saw more than 110 clinical trials take place. Their topic of study included cannabis as a treatment for Parkinson’s, multiple sclerosis (MS), Crohn’s disease and several other forms of chronic pain. Israel dominates the medical marijuana research space and the Government has plans to build one of the world’s most extensive medical cannabis research and development facilities in the world.

Andy Jagpal, President, Comments:
“We are excited to strike a relationship to develop a CBD infused energy drink as Canada’s edible marijuana market is around the corner from being fully legal within the year. We are also in contact with processors in Canada to manufacture the energy drink and with our Saskatchewan-based hemp farmers to source the CBD for our products.”

About Bougainville Ventures, Inc.  
Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost.

For more information please visit: http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-888-395-6399

Marijuana Company of America $MCOA Signs Letter of Intent to Cultivate Large Hemp Farm in California $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:38 AM on Tuesday, May 14th, 2019
  • Signed a Letter of Intent with Essence Farms, LLC, to form a joint venture (“JV”) called Riverside Hemp Project to run farming operations in California for the purpose of growing, cultivating, manufacturing, extracting and selling legal hemp and hemp-derived CBD.
  • Marijuana Company of America will provide hemp seeds, genetics, management of operations and standard operating procedures. Essence, a cultivator and land owner, will provide all necessary licenses for the legally compliant growth and sale of hemp in Riverside, California.

ESCONDIDO, Calif., May 14, 2019 (GLOBE NEWSWIRE) — via NetworkWire – MARIJUANA COMPANY OF AMERICA, INC., (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, announced today that the Company has signed a Letter of Intent (“LOI”) with Essence Farms, LLC, (“Essence”) to form a joint venture (“JV”) called Riverside Hemp Project to run farming operations in California for the purpose of growing, cultivating, manufacturing, extracting and selling legal hemp and hemp-derived CBD.

Through the agreement, Marijuana Company of America will provide hemp seeds, genetics, management of operations and standard operating procedures. Essence, a cultivator and land owner, will provide all necessary licenses for the legally compliant growth and sale of hemp in Riverside, California.

“MCOA strives to be a leader in producing and distributing hemp, and we believe this joint venture will allow the Company to further its vision by establishing itself as a premier company in the hemp sector,” said Don Steinberg, Chief Executive Officer of Marijuana Company of America. “With the ongoing return of net profits this project is expected to provide MCOA, we are confident that signing this Letter of Intent is another strategic step for the Company and we look forward to expanding further in both the cannabis and hemp markets in California. If all goes according to plan, this will by far be the most financially successful venture the Company has been involved in.”

Marijuana Company of America will receive an 80% return of net profits for the JV on an ongoing basis, as well as a long-term lease on the property with favorable lease terms. The project includes up to 500 usable acres of land in California’s Riverside County that has sufficient water and power and is specifically suited for large-scale cultivation. The Company is in the process of sourcing the highest quality seeds that will yield a high percentage of CBD with legally compliant low levels of THC. It is projected that each acre will produce 2,500 pounds of hemp biomass. Based on prevailing fair market rates at this time, the biomass can be sold for approximately $35 a pound. If the Company processes the biomass as it intends to do, at least in part, the biomass will produce a significantly higher financial return. Additionally, the property is equipped with several large structures that are suitable for the storage and drying of the hemp plants. A highly experienced cultivation team has been engaged to manage the operations and cultivation of the farm.

Consummation of the transaction remains contingent upon satisfactory completion of due diligence by both parties and completion and agreement on all final terms and conditions of the engagement. Further details on the terms of this LOI are available in the Company’s filing, which can be accessed at www.sec.gov.

About Marijuana Company of America, Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™, which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward-Looking Statements
This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities, and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212-418-1217 Office
[email protected]

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Primary Logo

CLIENT FEATURE: North Bud Farms $NBUD.ca Sustainable Low Cost, High Quality #Cannabinoid Production and Procurement $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 11:03 AM on Monday, May 13th, 2019

North Bud Farms Signs Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor

  • Transaction valued at CAD$20 million
  • In 2018, Eureka recognized revenue of approximately CAD$11.5 million*
    • net profit margin of 16%* from its California and Colorado operations
  • Anticipates further growth in revenue due to anticipated changes to retail regulation of adult cannabis use in California.

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products

Cultivation facility is progressing on schedule and on budget, video update below:

Click Image Below

FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.

North Bud Farms Inc. $NBUD.ca – ‘Game changer’: Health Canada changes cannabis licensing process $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:00 PM on Thursday, May 9th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE

—————

‘Game changer’: Health Canada changes cannabis licensing process

By David George-Cosh

Health Canada is changing the way it issues cannabis industry licences in a move that will likely alleviate a bottleneck that observers attribute to a long-running shortage of legal pot in the country.

Effective immediately, the regulator says new applicants seeking to produce, sell or process cannabis must already have a fully built facility. Previously, applicants were only required to make a paper submission.

“This is a game changer,” said Matt Maurer, a cannabis lawyer with Torkin Manes LLP, in a phone interview with BNN Bloomberg.

“We go from a situation where if you wanted to submit an application, you submit your paperwork and you sit and wait to hear back from Health Canada,” he said. “Now you’re asked to build a $30-million to $40-million facility before you even submit your application.”

Health Canada said it is making these changes after reviewing its existing process where more than 70 per cent of applicants whose paperwork was approved over the last three years failed to provide evidence of a having a cannabis facility that meets regulatory requirements.  

“As a result, a significant amount of resources are being used to review applications from entities that are not ready to begin operations, contributing to wait times for more mature applications and an inefficient allocation of resources,” Health Canada said in a release Wednesday.

Industry applicants have previously complained to Health Canada about the time it takes to become licensed as well as the number of current applications waiting for approval.

For example, Aphria Inc. interim chief executive officer Irwin Simon said in January during a call with analysts that his company was still waiting for Health Canada to approve licensing for an expansion to one of its facilities in Leamington, Ont. despite submitting an application with the regulator in early 2018. The company received licensing for the facility in March.

“This is not a slam against Health Canada. It’s just we as an entire industry were not fully prepared for the [consumer] onslaught,” Simon said. “We have great pent-up demand; we are impatiently waiting, but we are waiting.”

Sherry Boodram, chief executive officer of cannabis consulting company CannDelta Inc. and a former Health Canada staffer, said the new licensing requirements will likely “hit the industry hard” and make it more difficult to get investors to commit to a cannabis-related project.

“Your business plan has to be sound and make sense,” she said in a phone interview with BNN Bloomberg. “It might deter some people who were thinking of getting into the industry, like the micro-cultivation type, because they need a lot of money up front.”

Health Canada said that since May 2017 it has licensed more than 129 new sites and counts more than 600,000 square metres of production space for legal cannabis – the equivalent of growing 1 million kilograms of legal pot in Canada annually, roughly the same amount consumed in the country.

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.

Source: https://www.bnnbloomberg.ca/game-changer-health-canada-changes-cannabis-licensing-process-1.1255720

Bougainville Ventures Inc $BOG.ca – 8 incredible facts about the booming US #marijuana industry #weed $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 11:00 AM on Wednesday, May 8th, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE
—————————————

8 incredible facts about the booming US marijuana industry

  • The US marijuana industry is worth billions of dollars, and is showing no signs of slowing down.
  • Ten US states have legalized recreational marijuana use, and 33 have legalized medicinal use.

The marijuana industry is booming in the United States.

From the $52 billion in sales the industry posted to the 76% increase in cannabis jobs this year, there are plenty of statistics to show marijuana’s startling contributions to the US economy.

Marijuana initiatives have swept through state legislatures in recent years. Recreational marijuana use is legal in 10 US states, while medicinal marijuana is legal in 33. Illinois became the most recent state to weigh the topic when Gov. JB Pritzker introduced a bill to legalize the drug on Saturday.

Now, the industry is showing no signs of slowing down.

Read on for eight interesting facts about the US marijuana industry:

The marijuana industry could soon be worth more than the GDP of 9 US states

Associated Press

Marijuana Business Factbook estimates the legal-marijuana industry’s economic impact in the US was between $20 billion and $23 billion in 2017. It estimates the economic impact could reach as high as $77 billion by 2022.

Those numbers are comparable to the GDPs of Idaho and West Virginia, which were both a tick over $77 billion in 2018, according to the Bureau of Economic Analysis. And it’s worth more than the GDP of nine states, including Delaware, Alaska, and both North and South Dakota.

Cannabis employs five times as many Americans as coal

Associated Press

New Frontier Data, a cannabis market-research and data-analysis firm, estimates that the US cannabis industry employs at least 250,000 people. And those are just the jobs that are directly involved with handling marijuana plants – others in the industry are harder to quantify, a New Frontier economist told the Associated Press.

Compare that to the size of one of the staple blue-collar industries, coal mining, which employed 52,300 in 2018.

Another study estimated the marijuana industry would grow to at least 330,000 jobs by 2022, a higher number than the 268,000 employees at US steel and iron mills.

The median marijuana salary is 10% higher than the US median salary

AP Photo/Steven Senne

The median salary in the marijuana industry salary was $58,511 in 2018, while the median salary for US workers as a whole was $52,863, according to Glassdoor data. That’s a difference of 10.7%.

Investors poured $10 billion into the North American marijuana industry in 2018

Investors poured more than $10 billion into the North American marijuana industry in 2018, according to the Associated Press. That’s twice the total amount invested in the previous three years.

And experts project that number will shoot up to $16 billion this year.

Source: https://markets.businessinsider.com/news/stocks/weed-us-marijuana-industry-facts-2019-5-1028177375#the-marijuana-industry-could-soon-be-worth-more-than-the-gdp-of-9-us-states1

Marijuana Company of America’s $MCOA #hempSMART Subsidiary Plans Separate Listing on the Vienna Exchange $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:37 AM on Wednesday, May 8th, 2019
15233 mcoa
  • Announced that its wholly owned subsidiary, hempSMART, Ltd., is taking steps to list on the Vienna Stock Exchange (H Smart SARL),
  • Intends to raise sufficient capital to expedite the rollout of its hempSMART™ product line in Europe.

Escondido, California–(May 8, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary, hempSMART, Ltd., is taking steps to list on the Vienna Stock Exchange (H Smart SARL), with the intention of raising sufficient capital to expedite the rollout of its hempSMART™ product line in Europe.

Marijuana Company of America plans to sell a minority interest of hempSMART, Ltd., currently engaged in developing and marketing the hempSMART brand in Europe, for up to $10 million. The Company expects that all of the necessary steps to trade on the Vienna exchange will be completed by the beginning of the third quarter of 2019.

Once listed, hempSMART, Ltd. will be one of the first U.S.-based hemp-derived cannabidiol (CBD) companies to do an initial listing on a European exchange, as most cannabis and hemp public companies opt to list in Europe as a secondary listing. This is a result of the Company’s commitment to prioritizing its marketing efforts in the burgeoning European cannabis, hemp and CBD markets, with future plans to expand further.

“We are very excited to do an IPO of hempSMART, Ltd. on such a reputable European exchange,” said Don Steinberg, CEO of Marijuana Company of America. “This is a huge leap forward to obtain the necessary capital to bolster our European launch and become a top hemp brand in Europe. Europe’s cannabis and hemp markets are undergoing a critical phase in their growth and this is the optimum time to establish our brand as a leader. To date, we have exceeded expectations at our London event in March. In order to capitalize on this positive market momentum, we have planned two additional events in England, with two more following in Liverpool and Birmingham.”

hempSMART, Ltd. is expected to enter Portugal later this month, with future plans to extend further in France, Germany and Austria. hempSMART, Ltd. markets and sells the Company’s hemp and hemp-based personal wellness products, including the U.S.-patented hempSMART Brain™, an effective wellness product formulated with proprietary composition of natural ingredients and CBD to enhance brain function.

Jesus Quintero, CFO of MCOA, stated, “This offering on the Vienna exchange will help to strengthen the worldwide valuation for our hempSMART brand. We are highly optimistic about the prospects of this offering and the financial success of hempSMART.”

Ian Harvey, COO of hempSMART, Ltd., commented, “The U.S. patent issuance is indicative of the advances the Company achieved, and is a testament to the Company’s continued commitment to produce unique products of the highest quality, which distinguishes hempSMART as a leader of hemp-based CBD products.”

About Marijuana Company of America, Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™,” which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward-Looking Statements
This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362

Corporate Communications Contact:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/44536

Marijuana Company of America $MCOA Issues 2019 Shareholder Letter $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:30 AM on Tuesday, May 7th, 2019
15233 mcoa

Recent Company highlights include:

  • Global expansion with the debut of its hempSMART™ products in the UK
  • Established joint venture in California to operate a California cannabis delivery service named Viva Buds™
  • Details of the joint venture partnership with Global Hemp Group, completed a successful first harvest late in 2018 and is now in position to monetize its hemp biomass
  • Strategic partnership with MassRoots (OTCQB: MSRT) to promote its hempSMART CBD product line

Escondido, California–(May 7, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, today announces that on May 1, 2019, the Company mailed a letter to its shareholders to update them on recent developments and new business opportunities. In the letter, the Company provided a discussion on its two current acquisitions underway a review of its recent financial and operating performance and details of its new Viva Buds™ brand that will serve as a manufacturing, distribution and retail delivery service for cannabis products in the state of California.

Recent Company highlights include:

  • Marijuana Company of America’s global expansion with the debut of its hempSMART™ products in the UK
  • The Company’s established joint venture in California to operate a California cannabis delivery service named Viva Buds™
  • Details of the joint venture partnership with Global Hemp Group, which completed a successful first harvest late in 2018 and is now in position to monetize its hemp biomass
  • A strategic partnership with MassRoots (OTCQB: MSRT) to promote its hempSMART CBD product line

“Our shareholder letter addresses our hemp research and growth business expansion, and the two joint ventures we started with Global Hemp Group Inc. last year, which includes a working hemp farm in Oregon that just completed its successful first harvest in late 2018,” said Mr. Don Steinberg, Chairman and CEO of Marijuana Company of America. “We are confident to now be strategically positioned to drive more revenue and expand exponentially into new markets with our products and business growth methods.”

To read the letter to shareholders in full, please visit: http://marijuanacompanyofamerica.com/investor-relations/

About Marijuana Company of America Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™ which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Empower $CBDT.ca Announces Second Tranche Closing of Debenture and Unit Offerings and Announces Board of Director Changes $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:58 PM on Monday, May 6th, 2019
Epw logo1
  • “The strong support of our financing round demonstrates that shareholders and investors have faith in our ability to execute on initiatives, as we establish vertical integration connecting patient efficacy…,” stated Steven McAuley, Empower Chairman and CEO.

VANCOUVER, May 3, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a growth oriented and diversified medical cannabis company, is pleased to announce the closing of the second tranche of a non-brokered private placement of unsecured convertible debentures (the “Debentures“), pursuant to which it has issued Debentures in the aggregate principal amount of $207,270, and the second tranche of a non-brokered private placement of an aggregate of 5,762,500 units of the Company (each, a Unit“) at a price of $0.10 per Unit for gross proceeds of $576,250, for combined total proceeds of $783,520 (together, the “Offerings“).

The proceeds of the Offerings are expected to be used by the Company for the completion of strategic acquisitions and for general working capital and corporate purposes.

“The strong support of our financing round demonstrates that shareholders and investors have faith in our ability to execute on initiatives, as we establish vertical integration connecting patient efficacy in our clinics with a diverse CBD product strategy and the backing of the science of extraction, all driven by data and analysis,” stated Steven McAuley, Empower Chairman and CEO.

RECENT HIGHLIGHTS

  • Intention to Launch CBD Extraction Facility The Company intends to open a fully functioning hemp-based CBD extraction facility in greater Portland, Oregon in Q2 2019, with the first extraction system expected to have the capacity to produce 6,000 kilograms of extracted product per year. The 5,000 sq. ft. facility in Sandy, OR has now been secured through a 5 year lease agreement and preparations are underway to begin licensing and permit requirements to commence operations in 2019.

  • Acquisition of Sun Valley Clinics Empower has completed the acquisition of the business of Sun Valley Certification Clinics Holdings LLC (“Sun Valley“), including its interests in certain affiliates, by way of a share acquisition. Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry. The current Sun Valley clinic locations are as follows:

    4218 W Dunlap Ave, Phoenix, AZ
    12801 W Bell Rd #145, Surprise, AZ
    4015 E Bell Rd #130, Phoenix, AZ
    2011 E University Dr, Mesa, AZ
    7074 E Speedway Blvd, Tucson, AZ
    2550 S Rainbow Blvd, Las Vegas, NV
  • Focus on CBD Product Sales Empower has commenced selling its proprietary line of CBD-based products called SOLLIEVO, through its network of company-owned clinics in the United States. Empower’s patient base and customers are expected to benefit from access to high margin derivative products, including CBD lotion, tinctures, spectrum oils, capsules, lozenges, patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet elixir hemp extract drops. Patients and customers will be able to access Empower’s home delivery and e-commerce platform.

  • CBD Market Demand The passing in the United States of the US$867 billion Agriculture Improvement Act (the “Farm Bill“) has legalized hemp and hemp-based products. This has created an opportunity for the production and sale of a variety of CBD-based products that can provide genuine help and effective relief to millions of people suffering from a variety of qualifying conditions. Recent reports and studies indicate the approval of the Farm Bill could create a US$20 billion industry by 2022.

  • Increased Patient Access With a rapidly expanding company-owned clinic network and significant expansion opportunity assuming the successful acquisition of the Sun Valley franchise model, Empower anticipates it will grow its total patient list substantially in the years ahead. This is expected to provide greater opportunity for treatment analysis using artificial intelligence (AI).

  • Market Leading Technology Empower utilizes a market-leading patient electronic management and POS system that is HIPAA compliant and provides insight to patient care. The Company supports remote patients using its tele-medicine portal, enabling patients who are unable to come to a location to benefit from a doctor consultation.

The Debentures bear interest at the rate of 6.0% per annum and mature on May 3, 2020, being 12 months from the closing of the Offerings (the “Closing“). The Debentures are convertible, at the option of the Company or the holder, into units of the Company (each, a “Debenture Unit“) at a conversion price of $0.11 per Debenture Unit, with each Debenture Unit consisting of one common share in the capital of the Company (each, a “Share“) and one share purchase warrant (each, a “Warrant“), with each Warrant exercisable into one Share (each, a “Warrant Share“) at a price of $0.16 per Warrant Share for a period of two years following the Closing, provided that the Company will have the right to accelerate the expiry date of the Warrants in the event that the closing sale price of the Shares on the Canadian Securities Exchange (the “CSE“) (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.

Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.16 per Warrant Share for a period of two years following the Closing, provided that the Company will have the right to accelerate the expiry date of the Warrants in the event that the closing sale price of the Shares on the CSE (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants. 

The Debentures and the Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the “Securities“), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings. None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.

The Company also announces that Emily Davis has resigned as a Director and member of the effective immediately. The Company thanks Ms. Davis for her valuable contributions.

In addition, the Company announces that Dustin Klein has been appointed as a Director in conjunction with the previously announced closing of the Sun Valley acquisition.

ABOUT EMPOWER

Empower is a leading multi-state operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower’s proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 165,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: the proposed acquisition of Sun Valley; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the expected location of the proposed CBD extraction facility; the effectiveness of the extraction technology; the size of the leased facility; the expected benefits for Empower’s patient base and customers; access to Empower’s home delivery and e-commerce platform; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that: the proposed acquisitions and partnerships, including the Sun Valley and Aibeida transactions, may not be completed on the terms expected or at all; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operation by Q2 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2019/06/c9104.html

Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-6274Copyright CNW Group 2019

North Bud Farms Inc. $NBUD.ca – More Canadians smoking up and buying it from legal sources $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:25 PM on Thursday, May 2nd, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE

—————

More Canadians smoking up and buying it from legal sources

  • A new report on cannabis use in Canada shows how many have tried it for the first time, how many smoke daily, and how many think it is okay to drive within two hours of smoking up.
  • It said 5.3-million Canadians or 18 per cent over the age of 15 admitted to using cannabis within the past three months
  • That is an increase from 14 per cent during the same period last year before legal recreational use.

By Adelle Loiselle

May 2, 2019

A new report on cannabis use in Canada shows how many have tried it for the first time, how many smoke daily, and how many think it is okay to drive within two hours of smoking up.

Statistics Canada released the report detailing use in the first quarter of 2019 Thursday.

It said 5.3-million Canadians or 18 per cent over the age of 15 admitted to using cannabis within the past three months. That is an increase from 14 per cent during the same period last year before legal recreational use. In Ontario, one in five residents used in the first quarter of 2019 compared to 14 per cent during that period in 2018.

An increase among men aged 45 to 64 partially explains the rise. It went up to 22 per cent from 16 per cent a year ago, while use among women remained stagnant at 13 per cent.

Some 646,000 people admitted to trying it for the first time, while others had used it in the past but tried it again after abstaining for years. Older users accounted for a third of all people who sampled for the first time.

The percentage of daily users did not change from 2018, but there were more weekly and occasional consumers.

The report also showed that more people are buying their cannabis from legal sources. Statistics Canada says 47 per cent of users obtained solely from legitimate sources, like the Ontario Cannabis Store or legal retail marijuana stores, while 38 per cent got it illegally, down from 51 per cent last year. The rest used a mix of legal and illegal sources.

Cannabis use and driving still present a safety concern. The agency said half of Canadians believe it is safe to drive after three hours of using cannabis, but 15 per cent believed it was safe to get behind the wheel less than two hours afterwards. Many of those who drove earlier also said they had been passengers in a vehicle where the driver consumed cannabis within two hours of driving.

More than half a million Canadians also confessed to either using cannabis right before going to work or while on the job. About 27 per cent of those people were daily users.

Source: https://blackburnnews.com/windsor/windsor-news/2019/05/02/canadian-smoking-buying-legal-sources/